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e.2012.02Abstract Background: Autonomic nervous system (ANS) dysfunction is one of the suggested
pathophysiological mechanisms of ﬁbromyalgia (FM). Its dysfunction may contribute to enhanced
pain and other clinical problems associated with FM. Previous studies showed conﬂicting results
regarding ANS function in FM. Some studies showed increased while others showed decreased
ANS activity in FM patients. Thus, the autonomic responses in FM patients need further elabora-
tion.
Aim of the work: The aim of this work was to evaluate the autonomic dysfunction in FM patients
clinically and electrophysiologically.
Subjects and methods: Twenty-ﬁve patients (23 females and 2 males) diagnosed as FM and 15
apparently healthy individuals served as a control group were included in this study. Patients were
subjected to thorough clinical examination and assessment of 1 – pain by McGill pain questionnaire
(MPQ), 2 – sleep by Visual Analogue Scale (VAS), 3 – depression by Hamilton Rating Scale for
Depression (HRSD) and 4 – functional status by Fibromyalgia impact questionnaire (FIQ). Assess-
ment of ANS function was carried out by tilt table test, measuring supine and standing blood pres-
sure (BP) and heart rate (HR) and sympathetic skin response (SSR) of the hands.
Results: Compared to controls, there was a statistically signiﬁcant decrease of standing systolic BP
standing, diastolic BP and standing HR as well as a statistically signiﬁcant increase in latency and
decrease in amplitude of SSR of the hands of the FM patients. HRSD was correlated positively withmanent address: Neurology
andria University, Egypt.
hoo.com (G.A.H. Achmawi).
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216 N. El-Sawy et al.supine systolic BP and standing diastolic BP while McGill pain questionnaire was correlated positively
with supine systolicBP.Moreover,VAS falling asleepwas correlatedpositivelywith standing systolicBP.
Conclusion: The studied FMpatients showedANS dysfunction in the form of abnormal responses to
active and passive changes in posture as well as abnormal SSR.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Fibromyalgia (FM) is characterized by chronic widespread pain
and also allodynia, a heightened and painful response to pres-
sure.1 However, FM symptoms are not restricted to pain and
other core symptoms including debilitating fatigue, sleep distur-
bance, and joint stiffness are reported as well.2 Some patients
may also report difﬁculty in swallowing,3 bowel and bladder
abnormalities,4 numbness and tingling5 and cognitive dysfunc-
tion.6 The pathophysiology of FM involves a number of fac-
tors, including abnormalities in the neuroendocrine and
autonomic nervous systems, genetic factors, psychosocial vari-
ables and environmental stressors that interact to amplify
pain.7,8 Evidence accumulating through years showed that
autonomic dysfunction is common in FM.9–15 Some of the
FM symptoms like sleep disturbances, fatigue, orthostatic
intolerance and excessive rate of syncope were attributed to
autonomic dysfunction in FM patients.14,16,17 Autonomic ner-
vous system (ANS) abnormalities may contribute to enhanced
pain and other clinical problems associated with FM via the
alteration of physiologic responses required for effective stress
management.7 It has been suggested that, due to a ceiling ef-
fect, the hyperactive sympathetic nervous system (SNS) of such
patients becomes unable to further respond to different stress-
ors (sympathetic hyperactivity with hyporeactivity). This ex-
plains the constant fatigue, morning stiffness, sleep disorders,
anxiety, decreased threshold for pain, pseudo-Raynaud’s phe-
nomenon, sicca symptoms and intestinal irritability that these
patients suffer from.18,19 The function of the ANS is difﬁcult to
evaluate in clinical practice. Changes in breathing pattern,
presence of mental stress, or even change of posture, alter
immediately and completely the sympathetic/parasympathetic
balance.20 Accordingly, assessment of ANS under these dy-
namic conditions will reﬂect to a great extent the body re-
sponse in similar real life situations. Noninvasive tests of
autonomic function are relatively easy to implement, but can
be difﬁcult to interpret.21 Among the tools that can be used
in this respect are active orthostatic stress test,22 heart rate var-
iability analysis,23 tilt table test24 and sympathetic skin re-
sponse.25 Increased sympathetic and decreased
parasympathetic activities were detected in FM patients26–28
which are related to heart rate (HR) variability14 and increased
blood pressure (BP),16 suggesting exaggerated autonomic
activity. However, other studies reported decreased BP13 and
reduced HR variability,11 suggesting a hypoactive ANS. More-
over, SSR study showed variable results in FM patients.29–31
Thus, based on these conﬂicting data, the autonomic responses
in FM patients need further elaboration.
Aim: The aim of this workwas to evaluate the autonomic dys-
function in FM patients clinically and electrophysiologically.2. Methods
The study included 25 patients diagnosed as FM syndrome
according to the American College of Rheumatology criteria
(ACR)1 selected from those attending the Physical Medicine,
Rheumatology & Rehabilitation Department, Faculty of
Medicine, Alexandria University. Patients with rheumatologic
diseases (as rheumatoid arthritis, osteoarthritis, spond-
yloarthropathy, systemic lupus erythematosus, etc.), vascular
diseases, endocrine or metabolic diseases and neurologic or
neuromuscular diseases were excluded. Fifteen apparently
healthy individuals served as a control group for the auto-
nomic tests and electrophysiological study. The study was ex-
plained to the participants and an informed consent was given
by each one. The study was approved by the local ethics
committee.2.1. Every patient was subjected to the following
– Detailed history taking (demographic data, history of pres-
ent condition, past history, family history and menstrual
history from female patients).
– General examination with stress on musculoskeletal exami-
nation (including tender points) and complete neurological
examination.
– Assessment of the clinical manifestations of FM by:
1. McGill pain questionnaire (MPQ)32,33 for pain severity
assessment.
2. Analogical Visual Scale for Sleep evaluation (VAS).34
3. Hamilton Rating Scale for Depression (HRSD)35 for
depression assessment.
4. Fibromyalgia impact questionnaire (FIQ)36 for func-
tional assessment.
– Assessment of autonomic nervous system in FM by:
1. Measuring supine and standing blood pressure (BP)
and heart rate (HR), i.e. active orthostatic stress test.
Sustained drops in systolic blood pressure
(>20 mmHg) or diastolic blood pressure (>10 mmHg)
after standing for 3 min that are not associated with an
increase in the pulse rate >30 beats per minute suggest
autonomic deﬁcit.20
2. Tilt table test, i.e. passive orthostatic test: At ﬁrst sub-
jects lied supine for 30 min and HR and BP were deter-
mined. Then the subject was tilted upright for 30–
45 min at an angle of 60–80. There are two types of
abnormal responses. One such response is orthostatic
hypotension, deﬁned as a reduction of systolic blood
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blood pressure of at least 10 mmHg. This hypotension
may induce syncope. The other type of abnormal
response is postural orthostatic tachycardia, which
consists of a sustained increase of heart rate of at least
30 beats per minute or a sustained pulse rate of 120
beats per minute.24
3. Sympathetic skin response (SSR)37: one hand testing
was performed for every patient as a measure for sym-
pathetic function using NIHON KOHDEN (Neuro-
pack) electrophysiological apparatus.3. Statistical analysis
Data were analyzed using SPSS software package version 18.0
(SPSS, Chicago, IL, USA). Quantitative data were expressed
using range, mean, standard deviation and median, while qual-
itative data were expressed in frequency and percent. Quantita-
tive data were analyzed using Student’s t-test to compare
between the two groups. Pearson coefﬁcient was used to ana-
lyze the correlation between any two quantitative variables.
P value was assumed to be signiﬁcant at 0.05 or less.38Table 1 The determined cutoff points of the studied
autonomic variables of the control group.
Parameters Upper limit Lower limit
Supine systolic BP (mmHg) 142.45 87.21
Supine diastolic BP (mmHg) 93.87 55.47
Supine HR (beat/min) 79.63 63.83
Standing systolic BP (mmHg) 131.05 76.29
Standing diastolic BP (mmHg) 83.82 50.18
Standing HR (beat/min) 102.47 75.39
SSR
Latency (s) 1.81 0.85
Amplitude (lV) 142 41.22
BP: blood pressure, HR: heart rate, SSR: sympathetic skin
response.4. Results
Twenty-ﬁve patients fulﬁlling the ACR criteria for the diagno-
sis of ﬁbromyalgia were enrolled in this study. Their median
age was 37 years (ranging from 20 to 60). The control group
consisted of 15 apparently healthy individuals, their median
age was 33 years (ranging from 22 to 56). Only two patients
(8%) were males and the majority 23 patients (92%) were fe-
males. The control group consisted of 3 males (20%) and 12
females (80%). There were no statistically signiﬁcant differ-
ences between both groups regarding age and gender
(p= 0.328 and 0.345, respectively). Fifteen patients (60%)
were married, 7 patients (28%) were single, 2 patients (8%)
were divorced and 1 patient (4%) was a widow. Thirteen pa-
tients (52%) had light work, 10 patients (40%) had heavy work
and 2 patients (8%) had no work. The median duration of
symptoms was 24 months (ranging from 6 to 84 months).
All patients had pain in the form of deep muscular aching,
throbbing, shooting, stabbing or intense burning pain, whereas
20 patients (80%) had fatigue. Eighteen patients (72%) had
normal bowel habits, while 7 patients (28%) had irregular bo-
wel habits. All patients had irregular sleep pattern in the form
of difﬁculty in going to sleep, waking up several times during
sleep, little amount of sleep and waking up tired.
Assessment of pain severity by MPQ revealed that the med-
ian score of the total pain rating index (T-PRI) was 9 (ranging
from 6 to 19) and that of the presenting pain intensity-visual
analogue scale (PPI-VAS) was 5 (ranging from 3 to 7), while
the median score of the overall intensity of total pain experi-
ence was 2 (ranging from 2 to 3). Furthermore, assessment
of sleep by VAS showed that the median score of the time it
took the patient to fall asleep was 40 min (ranging from 30
to 60 min) and that of the amount of sleep the patient slept
was 50 min (ranging from 40 to 80 min) whereas the median
score of the quality of sleep of the patient was 50 (ranging from
30 to 60).
The median score of depression assessment of the studied
FM patient by HRSD was 19 (ranging from 12 to 48). Sixteenpatients (64%) had mild, 5 patients (20%) had severe, and 4
patients (16%) had moderate depression.
On the other hand, the median score of FIQ was 49.40
(ranging from 44 to 70). Thirteen patients (52%) showed mild
afﬂiction, 12 patients (48%) showed moderate afﬂiction and
none of them had severe afﬂiction.
4.1. Assessment of autonomic dysfunction
Table 1 shows the cutoff points of supine and standing systolic
BP, diastolic BP, HR as well as SSR latency and amplitude of
the controls.
Table 2 shows comparison between patients and controls
regarding the assessment of clinical autonomic dysfunction
of ﬁbromyalgia. There was a statistically signiﬁcant decrease
of standing systolic BP, diastolic BP, standing heart rate in
FM patients.
Fifteen patients showed decrease in standing systolic BP.
Five patients showed decrease in standing diastolic BP, 10 pa-
tients (40%) showed decrease in standing heart rate compared
to the control group.
Tilt table test was positive (abnormal response in the form
of orthostatic hypotension which may induce syncope and pos-
tural orthostatic tachycardia) in 16 patients (64%) and nega-
tive (normal response in the form of increased heart rate of
10–15 beat/min) in 9 patients (36%). All controls had negative
test.
Table 3 shows the results of SSR. There was a statistically
signiﬁcant increase in latency and decrease in amplitude of
SSR of the hands of the patients compared to control
(p= 0.001).
On descriptive analysis, 12 patients (48%) had prolonged
latency, 7 patients (28%) had normal latency and 1 patient
(4%) had short latency. Moreover, 15 patients (60%) had
low amplitude and 5 patients (20%) had normal amplitude.
In addition, there were 5 patients (20%) showing unobtainable
response.
Table 4 shows that MPQ was correlated negatively with
sleep VAS and positively with HRSD and FIQ, while FIQ
was correlated positively with HRSD.
On the other hand, different autonomic signs were corre-
lated positively with each other, Table 5.
In Table 5, correlation between different FM question-
naires and autonomic signs shows that HRSD was correlated
Table 2 Comparison between patients and controls regarding the assessment of autonomic dysfunction of ﬁbromyalgia.
Parameters Patients Controls t p
Supine systolic BP (mmHg)
Range 90.0–140.0 90.0–140.0 0.262 0.795
Mean ± SD 114.20 ± 13.04 115.33 ± 13.56
Median 110.00 110.00
Supine diastolic BP (mmHg)
Range 60.0–90.0 60.0–90.0 0.023 0.982
Mean ± SD 74.60 ± 8.89 74.67 ± 9.15
Median 80.00 70.00
Supine HR (beat/min)
Range 63.0–85.0 66.0–77.0 0.673 0.505
Mean ± SD 70.52 ± 6.25 71.73 ± 3.95
Median 70.00 70.00
Standing systolic BP (mmHg)
Range 60.0–130.0 70.0–120.0 2.366* 0.023
Mean ± SD 92.40 ± 15.078 103.67 ± 13.69
Median 90.00 100.00
Standing diastolic BP (mmHg)
Range 50.0–70.0 50.0–80.0 2.648* 0.012
Mean ± SD 60.0 ± 7.90 67.0 ± 8.41
Median 60.00 65.00
Standing HR (beat/min)
Range 68.0–90.0 80.0–100.0 4.211* 0.001
Mean ± SD 78.80 ± 7.70 88.93 ± 6.77
Median 77.00 90.00
Tilt table test Number % Number %
Negative 9 36.0 15 100 – –
Positive 16 64.0 0 0.0
BP: blood pressure, HR: heart rate, SSR: sympathetic skin response.
* p is signiﬁcant at 0.05 or less.
Table 3 Comparison between patients and controls regarding
the SSR of the hands.
SSR Patients
(25 hands)
Controls
(15 hands)
t p
Latency (s)
Range 0.50–3.63 1.0–1.98 3.929* 0.001
Mean ± SD 2.21 ± 0.96 1.33 ± 0.24
Median 2.31 1.29
Amplitude (lV)
Range 0.0–110.0 60.0–132.0 6.466* 0.001
Mean ± SD 28.31 ± 32.62 92.0 ± 25.39
Median 20.00 89.00
SSR: sympathetic skin response.
* p is signiﬁcant at 0.05 or less.
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while McGill pain questionnaire was correlated positively with
supine systolic BP. Moreover, VAS falling asleep was corre-
lated positively with standing systolic blood pressure and
VAS sleep quality was correlated positively with tender points
count (r= 0.467, p= 0.019).
Among the different parameters, SSR amplitude showed
signiﬁcant negative correlation with MPQ (r= 0.403,
p= 0.046) and HRSD (r= 0.428, p= 0.033).
5. Discussion
The current study was carried out to evaluate the autonomic
changes in FM patients and their relationship to the clinical
presentation of such patients.
Clinical assessment of the studied FM patients demon-
strated that the wide spread pain is a cardinal and constant
feature of the disease in all patients as assessed by the MPQ.
These ﬁndings were in agreement with those of Russel39 and
others.40,41 Moreover, all the studied patients had abnormal
sleep pattern which was in agreement with Roizenblatt
et al.42 and Blotmann et al.43 In addition, most of our patients
(64%) exhibited features of mild depression as assessed by
HRSD. High prevalence of depressive disorders in FM was
also demonstrated by Fietta et al.44 Accordingly, it was not
surprising that our patients had mild-moderate afﬂictionregarding the impact of FM on their quality of life as assessed
by FIQ.
Although FM etiopathogenesis is likely multifactorial,
there is no consensus about which mechanisms underlie the di-
verse symptoms of FM.44,45 However, it was suggested that
dysregulation of ANS, speciﬁcally an overactive SNS is impor-
tant in FM.46,47
In the present study, assessment of both sympathetic and
parasympathetic nervous systems was carried out. The former
Table 4 Correlation between the different questionnaires.
Parameters r p
MPQ T PRI
 VAS sleep amount 0.486* 0.014
 HRSD 0.693* 0.001
 FIQ 0.546* 0.005
MPQ PPI-VAS
 HRSD 0.483* 0.014
MPQ overall pain intensity
 HRSD 0.520* 0.008
VAS amount of sleep
 HRSD 0.449* 0.024
HDRS
 FIQ 0.789* 0.001
MPQ T PRI: McGill pain questionnaire – total pain rating index,
MPQ PPI-VAS: McGill pain questionnaire present pain intensity-
visual analogue scale, HRSD: Hamilton Rating Scale for Depres-
sion, FIQ: ﬁbromyalgia impact questionnaire.
* p is signiﬁcant at 0.05 or less.
Table 5 Correlation between autonomic signs and different
questionnaires.
Parameters r p
Supine systolic BP
 MPQ overall pain intensity 0.406* 0.044
 HDRS 0.422* 0.036
Standing systolic BP
 VAS falling sleep 0.413* 0.040
Standing diastolic BP
 HDRS 0.429* 0.032
BP: blood pressure, MPQ: McGill pain questionnaire, VAS: visual
analogue scale, HRSD: Hamilton Rating Scale for Depression.
* p is signiﬁcant at 0.05 or less.
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(BP) response to change in posture and by SSR and the latter
was assessed by heart rate (HR) variability with the change in
posture.48 The change in posture (orthostatic test) was active
(when standing from supine is actively assumed) and passive
(by tilting using a tilt table).22,48
Blood pressure normally changes only slightly on standing
from a sitting or supine position. The response to standing is
mediated by sympathetic nerve ﬁbers. A response is considered
abnormal when the diastolic blood pressure decreases more
than 10 mmHg or the systolic blood pressure falls by
30 mmHg within 2 min after standing.49 If reﬂex pathways
are defective, blood pressure falls markedly with hemodynamic
pooling. In tilt table testing, an abnormal response is deﬁned
similarly to that associated with active standing.50 Active
orthostatic stress is believed to be better than the passive tilting
test to trigger vagus-mediated reﬂexes.22 However, passive
head-up tilting provides a more precise level of standardization
to the orthostatic stimulus and reduces the muscular contrac-
tion of the legs, which can reduce lower-leg pooling of blood.50
In the present study, results of active orthostasis revealed a
statistically signiﬁcant decrease in standing systolic and dia-
stolic blood pressure and a signiﬁcant decrease in standingheart rate in FM patients. These ﬁndings denote normal rest-
ing (supine) autonomic function which changed during active
orthostasis where our patients exhibited SNS dysfunction as
manifested by the BP changes and failure of suppression of
the vagal inﬂuence on heart rate. Moreover, parasympathetic
(PSNS) dysfunction, as indicated by bradycardia, can not be
excluded. This was in agreement partially with a Martinez-
Lavin et al., study,11 They found the derangement of sympa-
thetic response in 19 FM patients which is markedly increased
in supine as compared to normal controls in the same posture
(unlike our results). Following an active orthostatic stress this
component is decreased in FM patients (like ours) while the
heart rate itself is increased (unlike ours).11 Keleman et al.12
also described a similar study with comparable results to
Martinez-Lavin et al.11 while Cohen et al.51 reported that the
patients with FM at rest are characterized by sympathetic
hyperactivity and concomitantly reduced parasympathetic
activity. During postural changes, patients demonstrated an
abnormal sympathovagal response. This was also in agreement
with the results of orthostatic test performed by Dog˘ru et al.8
They detected decreased parasympathetic and increased sym-
pathetic activities during orthostatic stress (stand and supine
tests) in FM patients.
Moreover, in the current study, 16 patients (64%) were
positive in tilt table test. This was in agreement with Bou-
Holaigah et al.13 Also, Naschitz et al.52 found that cardiovas-
cular response to upright tilt table test was signiﬁcantly
different in FM patient. In another study performed by Furlan
et al.,16 the effect of head-up tilt table test and muscular
sympathetic nerve activity was evaluated in FM patients. They
concluded that patients with FM have an overall enhancement
of cardiovascular sympathetic activity during recumbency
(unlike our results). The lack of increased sympathetic
discharge to vessels and decreased cardiac vagal activity
characterizes their autonomic proﬁle during tilt test, and might
account for the excessive rate of syncope.16
Accordingly, the pre-mentioned studies demonstrated ANS
dysregulation in FM manifested by basal (at rest) sympathetic
hyperactivity and concomitantly reduced parasympathetic
activity (unlike our results). Not only at rest but also there is
an abnormal autonomic response to different stressors includ-
ing postural changes (similar to our results). The abnormal
sympathovagal response to postural changes in FM patients
indicates that the activation of one or more groups of arterial
or cardiopulmonary baroreceptors may be impaired and thus
contribute to the inadequate response.13 Another proposed
explanation for the abnormal postural responses of FM
patients to postural changes is attributed to the basic physio-
logical principle that chronic hyper-stimulation of the beta-
adrenergic receptors at rest leads to receptor desensitization
and down-regulation preventing further response in stressful
situations.20 The latter explanation can not ﬁt with our study
because our results showed that FM patients had normal auto-
nomic activity at rest. The difference between our results and
others may be related to the difference in the methodology
used to assess autonomic dysfunction.
In the present study there was a statistically signiﬁcant in-
crease in SSR latency of patients and a statistically signiﬁcant
decrease in SSR amplitude of patients. Our results agreed par-
tially with those of Ulas et al.,53 who found that the latencies
of SSR recorded from both palms and soles of 34 female FM
patients were signiﬁcantly longer than the healthy subjects.
220 N. El-Sawy et al.Moreover, Unlu et al.29 investigated the autonomic dysfunc-
tion in FMS by recording SSR from palmar, plantar and gen-
ital regions in 28 FM married female patients and 18 married
healthy females. They found that the amplitude of SSR re-
corded from palmar, plantar and genital regions was lower
than in the control subjects.29 In contrast to our results, C¸akir
et al.,30 observed a statistically signiﬁcant decrease in distal la-
tency, and a statistically signiﬁcant increase in amplitude of
SSR in FM patients suggestive of sympathetic overactivity.
Ozgocmen et al.,31 studied SSR in 29 female patients with
FM and 22 healthy age-matched female controls. SSR laten-
cies of patients’ hands and feet had no signiﬁcant difference
compared to the controls.31 The controversial results in the lit-
erature regarding SSR whether decreased, increased or normal
may support the notion that here is a great variability of SSR
reproducibility among normal individuals.54 However, based
on the results of the different studies, it can be assumed that
involvement of the sympathetic cholinergic system is not as fre-
quent and consistent as that of the adrenergic system. In our
study, both systems are signiﬁcantly affected in FM patients.
The abnormal SSR latency in our study can be attributed to
the presence of a neuropathy affecting unmyelinated/poorly
myelinated ﬁbers more than a cholinergic dysfunction in the
transmission between the nervous output and the sweat glands
as the efferent unmyelinated ﬁbers accounting for most of the
latency, although a slow conduction in the afferent branch of
the reﬂex arc, or central delay in the activation of sympathetic
neurons, may cause relevant changes. Moreover, the amplitude
of response is highly variable and its decrease is related to a de-
creased sympathetic outﬂow. However, the main clinical con-
sideration remains the presence/absence of the response.55
In the present study, MPQ was negatively correlated with
VAS of sleep amount. This was in agreement with a study per-
formed by Roizenblatt et al.,42 where sleep quality was signif-
icantly lower in patients with FM than in controls and patients
reported worsening of pain symptoms after poor sleep.42
Moreover, a large epidemiologic study supports the correla-
tion between sleep and pain.56 The negative correlation be-
tween the number of tender points and the VAS sleep
quality in the present study denotes that with increasing num-
ber of tender points sleep quality becomes worse. Disturbed
sleep may contribute to enhanced pain because it was found
that the abnormal EEG pattern during sleep was associated
with the reduced production of growth hormone and IGF-1
which are necessary for the repair of muscle microtrauma.
Thus, sleep disturbances may impair the healing of muscle tis-
sue damage and enhance the perception of muscle pain.57
Moreover, in the present study, FIQ was positively corre-
lated with MPQ and HRSD (excessive pain and depression
were associated with poor quality of life of the FM patients)
and MPQ was also positively correlated with HRSD. In one
study, it was found that the symptoms and the resulting dis-
ability of FM are strongly related to the feelings of anxiety
and apprehension regarding the nature and prognosis of the
condition (‘illness worry’), to a greater extent than in RA.58
Although most of the studies showed a signiﬁcant adverse ef-
fect of anxiety on the quality of life of FM patients, it is also
easy to infer that depression has the same effect as our results.
In the current study, standing systolic and diastolic BP
showed positive correlations with VAS falling asleep and
HRSD respectively denoting that sympathetic overactivity
may affect the sleep pattern and psychological state of thepatient. However, these effects showed some inconsistency
with the available literature. Most of the available studies
showed adverse effects of ANS dysfunction in FM on
sleep.14,42,43,59 Most of these studies attributed sleep distur-
bance in FM patients to the changes in nocturnal autonomic
activity and the clinical impact of this autonomic circadian dis-
turbance on FM patients.14,42,43,59 On the other hand, most of
the studies found an association between ANS dysfunction in
FM patients and anxiety (not depression). In one study, dia-
stolic BP and HR were negatively related to stress, pain, and
anxiety.45 While in another one, it was concluded that anxi-
ety-induced stress is known to evoke the behavioral alerting re-
sponse in humans, which is associated with an increase in
sympathetic activity and a decrease in parasympathetic activity
to the heart.59,60
From this study, it can be concluded that FM patients had
ANS dysfunction in response to active and passive changes in
posture involving both sympathetic (detected by blood pres-
sure changes) and parasympathetic components (detected by
heart rate changes), i.e. there is an abnormal sympathovagal
response in our FM patients. The cholinergic component of
the SNS (detected by SSR abnormalities) was also hypoactive.
The ANS dysfunction in the current study manifested predom-
inantly by hypoactive SNS.
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